vs
Protalix BioTherapeutics, Inc.（PLX）与Valaris Ltd（VAL）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Valaris Ltd的1.8倍（$9.1M vs $5.2M），Valaris Ltd净利率更高（13798.1% vs -60.3%，领先13858.4%），Valaris Ltd同比增速更快（405.9% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-34.1M），过去两年Valaris Ltd的营收复合增速更高（29.5% vs -6.7%）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
瓦拉瑞斯有限公司是全球领先的海上钻井承包商，总部位于美国得克萨斯州休斯敦，注册地为百慕大，是全球规模最大的海上钻井及油井钻井服务企业。截至2025年2月，公司共运营52座钻井平台，包含36座海上自升式钻井平台、11艘钻井船以及5座半潜式钻井平台。
PLX vs VAL — 直观对比
营收规模更大
PLX
是对方的1.8倍
$5.2M
营收增速更快
VAL
高出455.8%
-49.9%
净利率更高
VAL
高出13858.4%
-60.3%
自由现金流更多
PLX
多$35.7M
$-34.1M
两年增速更快
VAL
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $5.2M |
| 净利润 | $-5.5M | $717.5M |
| 毛利率 | 49.4% | -7850.0% |
| 营业利润率 | -51.1% | — |
| 净利率 | -60.3% | 13798.1% |
| 营收同比 | -49.9% | 405.9% |
| 净利润同比 | -184.8% | 436.6% |
| 每股收益（稀释后） | $-0.06 | $10.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXVAL
| Q4 25 | $9.1M | $5.2M | ||
| Q3 25 | $17.9M | $5.6M | ||
| Q2 25 | $15.7M | $700.0K | ||
| Q1 25 | $10.1M | — | ||
| Q4 24 | $18.2M | $-1.7M | ||
| Q3 24 | $18.0M | $3.9M | ||
| Q2 24 | $13.5M | $4.8M | ||
| Q1 24 | — | $2.6M |
净利润PLXVAL
| Q4 25 | $-5.5M | $717.5M | ||
| Q3 25 | $2.4M | $188.1M | ||
| Q2 25 | $164.0K | $115.1M | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $6.5M | $133.7M | ||
| Q3 24 | $3.2M | $64.6M | ||
| Q2 24 | $-2.2M | $149.6M | ||
| Q1 24 | — | $25.5M |
毛利率PLXVAL
| Q4 25 | 49.4% | -7850.0% | ||
| Q3 25 | 53.4% | -7142.9% | ||
| Q2 25 | 62.5% | -56428.6% | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 78.7% | 24529.4% | ||
| Q3 24 | 53.4% | -11748.7% | ||
| Q2 24 | 29.8% | -9039.6% | ||
| Q1 24 | — | -17007.7% |
营业利润率PLXVAL
| Q4 25 | -51.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | -41.0% | — | ||
| Q4 24 | 39.6% | — | ||
| Q3 24 | 22.2% | — | ||
| Q2 24 | -18.0% | — | ||
| Q1 24 | — | — |
净利率PLXVAL
| Q4 25 | -60.3% | 13798.1% | ||
| Q3 25 | 13.2% | 3358.9% | ||
| Q2 25 | 1.0% | 16442.9% | ||
| Q1 25 | -35.8% | — | ||
| Q4 24 | 35.6% | -7864.7% | ||
| Q3 24 | 18.0% | 1656.4% | ||
| Q2 24 | -16.4% | 3116.7% | ||
| Q1 24 | — | 980.8% |
每股收益（稀释后）PLXVAL
| Q4 25 | $-0.06 | $10.13 | ||
| Q3 25 | $0.03 | $2.65 | ||
| Q2 25 | $0.00 | $1.61 | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $0.10 | $1.86 | ||
| Q3 24 | $0.03 | $0.88 | ||
| Q2 24 | $-0.03 | $2.03 | ||
| Q1 24 | — | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $599.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $48.2M | $3.2B |
| 总资产 | $82.3M | $5.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PLXVAL
| Q4 25 | $14.7M | $599.4M | ||
| Q3 25 | $13.6M | $662.7M | ||
| Q2 25 | $17.9M | $503.4M | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $19.8M | $368.2M | ||
| Q3 24 | $27.4M | $379.3M | ||
| Q2 24 | $23.4M | $398.3M | ||
| Q1 24 | — | $494.1M |
股东权益PLXVAL
| Q4 25 | $48.2M | $3.2B | ||
| Q3 25 | $52.9M | $2.4B | ||
| Q2 25 | $49.9M | $2.3B | ||
| Q1 25 | $45.2M | — | ||
| Q4 24 | $43.2M | $2.2B | ||
| Q3 24 | $32.4M | $2.1B | ||
| Q2 24 | $28.6M | $2.2B | ||
| Q1 24 | — | $2.0B |
总资产PLXVAL
| Q4 25 | $82.3M | $5.3B | ||
| Q3 25 | $82.3M | $4.6B | ||
| Q2 25 | $78.5M | $4.5B | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $73.4M | $4.4B | ||
| Q3 24 | $61.6M | $4.3B | ||
| Q2 24 | $91.5M | $4.4B | ||
| Q1 24 | — | $4.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $72.2M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | $-34.1M |
| 自由现金流率自由现金流/营收 | 17.8% | -655.8% |
| 资本支出强度资本支出/营收 | 4.4% | 2044.2% |
| 现金转化率经营现金流/净利润 | — | 0.10× |
| 过去12个月自由现金流最近4个季度 | $-13.6M | $159.9M |
8季度趋势，按日历期对齐
经营现金流PLXVAL
| Q4 25 | $2.0M | $72.2M | ||
| Q3 25 | $-3.7M | $198.1M | ||
| Q2 25 | $-5.2M | $120.0M | ||
| Q1 25 | $-5.1M | — | ||
| Q4 24 | $4.0M | $124.6M | ||
| Q3 24 | $4.1M | $193.0M | ||
| Q2 24 | $-3.6M | $11.5M | ||
| Q1 24 | — | $26.3M |
自由现金流PLXVAL
| Q4 25 | $1.6M | $-34.1M | ||
| Q3 25 | $-4.2M | $128.3M | ||
| Q2 25 | $-5.7M | $52.8M | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $3.6M | $12.9M | ||
| Q3 24 | $4.0M | $111.1M | ||
| Q2 24 | $-3.8M | $-98.7M | ||
| Q1 24 | — | $-125.0M |
自由现金流率PLXVAL
| Q4 25 | 17.8% | -655.8% | ||
| Q3 25 | -23.7% | 2291.1% | ||
| Q2 25 | -36.2% | 7542.9% | ||
| Q1 25 | -53.0% | — | ||
| Q4 24 | 19.6% | -758.8% | ||
| Q3 24 | 22.4% | 2848.7% | ||
| Q2 24 | -28.1% | -2056.3% | ||
| Q1 24 | — | -4807.7% |
资本支出强度PLXVAL
| Q4 25 | 4.4% | 2044.2% | ||
| Q3 25 | 2.8% | 1246.4% | ||
| Q2 25 | 2.8% | 9600.0% | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 2.3% | -6570.6% | ||
| Q3 24 | 0.5% | 2100.0% | ||
| Q2 24 | 1.3% | 2295.8% | ||
| Q1 24 | — | 5819.2% |
现金转化率PLXVAL
| Q4 25 | — | 0.10× | ||
| Q3 25 | -1.58× | 1.05× | ||
| Q2 25 | -31.91× | 1.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | 0.93× | ||
| Q3 24 | 1.27× | 2.99× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
VAL
暂无分部数据
